| Literature DB >> 28835615 |
Bertrand Miannay1,2, Stéphane Minvielle2,3, Olivier Roux1, Pierre Drouin1, Hervé Avet-Loiseau4, Catherine Guérin-Charbonnel2,5, Wilfried Gouraud2,5, Michel Attal6, Thierry Facon7, Nikhil C Munshi8,9, Philippe Moreau2,3, Loïc Campion2,5, Florence Magrangeas10,11, Carito Guziolowski12.
Abstract
Innovative approaches combining regulatory networks (RN) and genomic data are needed to extract biological information for a better understanding of diseases, such as cancer, by improving the identification of entities and thereby leading to potential new therapeutic avenues. In this study, we confronted an automatically generated RN with gene expression profiles (GEP) from a cohort of multiple myeloma (MM) patients and normal individuals using global reasoning on the RN causality to identify key-nodes. We modeled each patient by his or her GEP, the RN and the possible automatically detected repairs needed to establish a coherent flow of the information that explains the logic of the GEP. These repairs could represent cancer mutations leading to GEP variability. With this reasoning, unmeasured protein states can be inferred, and we can simulate the impact of a protein perturbation on the RN behavior to identify therapeutic targets. We showed that JUN/FOS and FOXM1 activities are altered in almost all MM patients and identified two survival markers for MM patients. Our results suggest that JUN/FOS-activation has a strong impact on the RN in view of the whole GEP, whereas FOXM1-activation could be an interesting way to perturb an MM subgroup identified by our method.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28835615 PMCID: PMC5569101 DOI: 10.1038/s41598-017-09378-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379